+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Hematology Drugs Global Market Report 2020-30: COVID-19 Impact and Recovery

  • ID: 5028639
  • Report
  • May 2020
  • Region: Global
  • 300 pages
  • The Business Research Company
1 of 5

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • Bayer AG
  • Biogen Inc
  • Daiichi Sankyo Company
  • Novo Nordisk A/S
  • Shire Plc
  • MORE
Hematology Drugs Global Market Report 2020-30: COVID-19 Impact and Recovery from the publisher provides the strategists, marketers and senior management with the critical information they need to assess the global hematology drugs market as it emerges from the COVID-19 shut down.

Reasons to Purchase
  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3 working days of order.
Description:
Where is the largest and fastest growing market for the hematology drugs? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Hematology Drugs market global report from the publisher answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography. It places the market within the context of the wider hematology drugs market, and compares it with other markets.
  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, the impact of the COVID-19 virus and forecasting its recovery.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the impact and recovery trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
  • The hematology drugs market section of the report gives context. It compares the hematology drugs market with other segments of the pharmaceutical drugs market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, hematology drugs indicators comparison.
Scope

Markets Covered:
1) By Type: Blood Products; Anemia And Other Blood Disorder Drugs
2) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies/ Drug Stores; Others
3) By Route Of Administration: Oral; Parenteral; Others
4) By Drug Classification: Branded Drugs; Generic Drugs
5) By Mode Of Purchase: Prescription-Based Drugs; Over-The-Counter Drugs

Companies Mentioned: Novo Nordisk A/S; Shire Plc; Bayer AG; Daiichi Sankyo Company; Biogen Inc

Metrics Covered: Number of Enterprises; Number of Employees

Countries: Argentina; Australia; Austria; Belgium; Brazil; Canada; Chile; China; Colombia; Czech Republic; Denmark; Egypt; Finland; France; Germany; Hong Kong; India; Indonesia; Ireland; Israel; Italy; Japan; Malaysia; Mexico; Netherlands; New Zealand; Nigeria; Norway; Peru; Philippines; Poland; Portugal; Romania; Russia; Saudi Arabia; Singapore; South Africa; South Korea; Spain; Sweden; Switzerland; Thailand; Turkey; UAE; UK; USA; Venezuela; Vietnam

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita, hematology drugs indicators comparison.

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

This report will be delivered within 1-3 business days.
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Bayer AG
  • Biogen Inc
  • Daiichi Sankyo Company
  • Novo Nordisk A/S
  • Shire Plc
  • MORE
1. Executive Summary

2. Report Structure

3. Hematology Drugs Market Characteristics
3.1. Market Definition
3.2. Key Segmentations

4. Hematology Drugs Market Product Analysis
4.1. Leading Products/ Services
4.2. Key Features and Differentiators
4.3. Development Products

5. Hematology Drugs Market Supply Chain
5.1. Supply Chain
5.2. Distribution
5.3. End Customers

6. Hematology Drugs Market Customer Information
6.1. Customer Preferences
6.2. End Use Market Size and Growth

7. Hematology Drugs Market Trends And Strategies

8. Hematology Drugs Market Size And Growth
8.1. Market Size
8.2. Historic Market Growth, Value ($ Billion)
8.2.1. Drivers Of The Market
8.2.2. Restraints On The Market
8.3. Forecast Market Growth, Value ($ Billion)
8.3.1. Drivers Of The Market
8.3.2. Restraints On The Market

9. Hematology Drugs Market Regional Analysis
9.1. Global Hematology Drugs Market, 2019, By Region, Value ($ Billion)
9.2. Global Hematology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Region
9.3. Global Hematology Drugs Market, Growth And Market Share Comparison, By Region

10. Hematology Drugs Market Segmentation
10.1. Global Hematology Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Blood Products
  • Anemia And Other Blood Disorder Drugs
10.2. Global Hematology Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Hospital Pharmacies
  • Retail Pharmacies/ Drug Stores
  • Others
10.3. Global Hematology Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Oral
  • Parenteral
  • Others
10.4. Global Hematology Drugs Market, Segmentation By Drug Classification, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Branded Drugs
  • Generic Drugs
10.5. Global Hematology Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Prescription-Based Drugs
  • Over-The-Counter Drugs
11. Hematology Drugs Market Metrics
11.1. Hematology Drugs Market Size, Percentage Of GDP, 2015-2023, Global
11.2. Per Capita Average Hematology Drugs Market Expenditure, 2015-2023, Global

12. Asia-Pacific Hematology Drugs Market
12.1. Asia-Pacific Hematology Drugs Market Overview
12.2. Asia-Pacific, Hematology Drugs Market, 2019, By Country, Value ($ Billion)
12.3. Asia-Pacific, Hematology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
12.4. Asia-Pacific, Hematology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
12.5. Asia-Pacific, Hematology Drugs Market Metrics
12.5.1. Per Capita Average Hematology Drugs Expenditure, 2015-2023, Asia-Pacific Countries
12.6. Asia-Pacific Hematology Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
12.7. Asia-Pacific Hematology Drugs Market: Country Analysis
12.7.1. China Hematology Drugs Market
12.7.1.1. China Hematology Drugs Market Overview
12.7.1.2. China Hematology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
12.7.1.3. China Hematology Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
12.7.2. Australia Hematology Drugs Market
12.7.2.1. Australia Hematology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
12.7.2.2. Australia Hematology Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
12.7.3. Hong Kong Hematology Drugs Market
12.7.3.1. Hong Kong Hematology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
12.7.4. India Hematology Drugs Market
12.7.4.1. India Hematology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
12.7.4.2. India Hematology Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
12.7.5. Indonesia Hematology Drugs Market
12.7.5.1. Indonesia Hematology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
12.7.5.2. Indonesia Hematology Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
12.7.6. Japan Hematology Drugs Market
12.7.6.1. Japan Hematology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
12.7.6.2. Japan Hematology Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
12.7.7. Malaysia Hematology Drugs Market
12.7.7.1. Malaysia Hematology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
12.7.8. New Zealand Hematology Drugs Market
12.7.8.1. New Zealand Hematology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
12.7.9. Philippines Hematology Drugs Market
12.7.9.1. Philippines Hematology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
12.7.10. Singapore Hematology Drugs Market
12.7.10.1. Singapore Hematology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
12.7.11. South Korea Hematology Drugs Market
12.7.11.1. South Korea Hematology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
12.7.11.2. South Korea Hematology Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
12.7.12. Thailand Hematology Drugs Market
12.7.12.1. Thailand Hematology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
12.7.13. Vietnam Hematology Drugs Market
12.7.13.1. Vietnam Hematology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

13. Western Europe Hematology Drugs Market
13.1. Western Europe Hematology Drugs Market Overview
13.2. Western Europe, Hematology Drugs Market, 2019, By Country, Value ($ Billion)
13.3. Western Europe, Hematology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
13.4. Western Europe, Hematology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
13.5. Western Europe, Hematology Drugs Market Metrics
13.5.1. Per Capita Average Hematology Drugs Expenditure, 2015-2023, Western Europe Countries
13.6. Western Europe Hematology Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
13.7. Western Europe Hematology Drugs Market: Country Analysis
13.7.1. Austria Hematology Drugs Market
13.7.1.1. Austria Hematology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
13.7.2. Belgium Hematology Drugs Market
13.7.2.1. Belgium Hematology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
13.7.3. Denmark Hematology Drugs Market
13.7.3.1. Denmark Hematology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
13.7.4. Finland Hematology Drugs Market
13.7.4.1. Finland Hematology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
13.7.5. France Hematology Drugs Market
13.7.5.1. France Hematology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
13.7.5.2. France Hematology Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
13.7.6. Germany Hematology Drugs Market
13.7.6.1. Germany Hematology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
13.7.6.2. Germany Hematology Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
13.7.7. Ireland Hematology Drugs Market
13.7.7.1. Ireland Hematology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
13.7.8. Italy Hematology Drugs Market
13.7.8.1. Italy Hematology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
13.7.9. Netherlands Hematology Drugs Market
13.7.9.1. Netherlands Hematology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
13.7.10. Norway Hematology Drugs Market
13.7.10.1. Norway Hematology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
13.7.11. Portugal Hematology Drugs Market
13.7.11.1. Portugal Hematology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
13.7.12. Spain Hematology Drugs Market
13.7.12.1. Spain Hematology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
13.7.13. Sweden Hematology Drugs Market
13.7.13.1. Sweden Hematology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
13.7.14. Switzerland Hematology Drugs Market
13.7.14.1. Switzerland Hematology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
13.7.15. UK Hematology Drugs Market
13.7.15.1. UK Hematology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
13.7.15.2. UK Hematology Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

14. Eastern Europe Hematology Drugs Market
14.1. Eastern Europe Hematology Drugs Market Overview
14.2. Eastern Europe, Hematology Drugs Market, 2019, By Country, Value ($ Billion)
14.3. Eastern Europe, Hematology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
14.4. Eastern Europe, Hematology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
14.5. Eastern Europe, Hematology Drugs Market Metrics
14.5.1. Per Capita Average Hematology Drugs Expenditure, 2015-2023, Eastern Europe Countries
14.6. Eastern Europe Hematology Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
14.7. Eastern Europe Hematology Drugs Market: Country Analysis
14.7.1. Czech Republic Hematology Drugs Market,
14.7.1.1. Czech Republic Hematology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
14.7.2. Poland Hematology Drugs Market
14.7.2.1. Poland Hematology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
14.7.3. Romania Hematology Drugs Market
14.7.3.1. Romania Hematology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
14.7.4. Russia Hematology Drugs Market
14.7.4.1. Russia Hematology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
14.7.4.2. Russia Hematology Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

15. North America Hematology Drugs Market
15.1. North America Hematology Drugs Market Overview
15.2. North America, Hematology Drugs Market, 2019, By Country, Value ($ Billion)
15.3. North America, Hematology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
15.4. North America, Hematology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
15.5. North America, Hematology Drugs Market Metrics
15.5.1. Per Capita Average Hematology Drugs Expenditure, 2015-2023, North America Countries
15.6. North America Hematology Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
15.7. North America Hematology Drugs Market: Country Analysis
15.7.1. Canada Hematology Drugs Market
15.7.1.1. Canada Hematology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
15.7.2. Mexico Hematology Drugs Market
15.7.2.1. Mexico Hematology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
15.7.3. USA Hematology Drugs Market
15.7.3.1. USA Hematology Drugs Market Overview
15.7.3.2. USA Hematology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
15.7.3.3. USA Hematology Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

16. South America Hematology Drugs Market
16.1. South America Hematology Drugs Market Overview
16.2. South America, Hematology Drugs Market, 2019, By Country, Value ($ Billion)
16.3. South America, Hematology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
16.4. South America, Hematology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
16.5. South America, Hematology Drugs Market Metrics
16.5.1. Per Capita Average Hematology Drugs Expenditure, 2015-2023, South America Countries
16.6. South America Hematology Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
16.7. South America Hematology Drugs Market: Country Analysis
16.7.1. Argentina Hematology Drugs Market
16.7.1.1. Argentina Hematology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
16.7.2. Brazil Hematology Drugs Market
16.7.1.1. Brazil Hematology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
16.7.2.2. Brazil Hematology Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
16.7.3. Chile Hematology Drugs Market
16.7.3.1. Chile Hematology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
16.7.4. Colombia Hematology Drugs Market
16.7.4.1. Colombia Hematology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
16.7.5. Peru Hematology Drugs Market
16.7.5.1. Peru Hematology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
16.7.6. Venezuela Hematology Drugs Market
16.7.6.1. Venezuela Hematology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

17. Middle East Hematology Drugs Market
17.1. Middle East Hematology Drugs Market Overview
17.2. Middle East, Hematology Drugs Market, 2019, By Country, Value ($ Billion)
17.3. Middle East, Hematology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
17.4. Middle East, Hematology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
17.5. Middle East, Hematology Drugs Market Metrics
17.5.1. Per Capita Average Hematology Drugs Expenditure, 2015-2023, Middle East Countries
17.6. Middle East Hematology Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
17.7. Middle East Hematology Drugs Market: Country Analysis
17.7.1. Saudi Arabia Hematology Drugs Market
17.7.1.1. Saudi Arabia Hematology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
17.7.2. Israel Hematology Drugs Market
17.7.2.1. Israel Hematology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
17.7.3. Turkey Hematology Drugs Market
17.7.3.1. Turkey Hematology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
17.7.4. UAE Hematology Drugs Market
17.7.4.1. UAE Hematology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

18. Africa Hematology Drugs Market
18.1. Africa Hematology Drugs Market Overview
18.2. Africa, Hematology Drugs Market, 2019, By Country, Value ($ Billion)
18.3. Africa, Hematology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
18.4. Africa, Hematology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
18.5. Africa, Hematology Drugs Market Metrics
18.5.1. Per Capita Average Hematology Drugs Expenditure, 2015-2023, Africa Countries
18.6. Africa Hematology Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
18.7. Africa Hematology Drugs Market: Country Analysis
18.7.1. Egypt Hematology Drugs Market
18.7.1.1. Egypt Hematology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
18.7.2. Nigeria Hematology Drugs Market
18.7.2.1. Nigeria Hematology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
18.7.3. South Africa Hematology Drugs Market
18.7.3.1. South Africa Hematology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

19. Hematology Drugs Market Competitive Landscape
19.1. Competitive Market Overview
19.2. Market Shares
19.3. Company Profiles
19.3.1. Novo Nordisk A/S
19.3.1.1. Company Overview
19.3.1.2. Products And Services
19.3.1.3. Strategy
19.3.1.4. Financial Performance
19.3.2. Shire Plc
19.3.2.1. Company Overview
19.3.2.2. Products And Services
19.3.2.3. Strategy
19.3.2.4. Financial Performance
19.3.3. Bayer AG
19.3.3.1. Company Overview
19.3.3.2. Products And Services
19.3.3.3. Strategy
19.3.3.4. Financial Performance
19.3.4. Daiichi Sankyo Company
19.3.4.1. Company Overview
19.3.4.2. Products And Services
19.3.4.3. Strategy
19.3.4.4. Financial Performance
19.3.5. Biogen Inc
19.3.5.1. Company Overview
19.3.5.2. Products And Services
19.3.5.3. Strategy
19.3.5.4. Financial Performance

20. Key Mergers And Acquisitions In The Hematology Drugs Market

21. Market Background: Pharmaceutical Drugs Market
21.1. Pharmaceutical Drugs Market Characteristics
21.2. Pharmaceutical Drugs Market Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F Growth, By Segment, Value ($ Billion), Global
21.3. Global Pharmaceutical Drugs Market, 2019, By Region, Value ($ Billion)
21.4. Global Pharmaceutical Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Region
21.5. Global Pharmaceutical Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Segmentation By Type, Value ($ Billion)

22. Recommendations
22.1. Global Hematology Drugs Market In 2023- Growth Countries
22.2. Global Hematology Drugs Market In 2023- Growth Segments
22.3. Global Hematology Drugs Market In 2023- Growth Strategies

23. Appendix
23.1. NAICS Definitions Of Industry Covered In This Report
23.2. Abbreviations
23.3. Currencies
23.4. Research Inquiries
23.5. About the Publisher

24. Copyright And Disclaimer
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5

FEATURED COMPANIES

  • Bayer AG
  • Biogen Inc
  • Daiichi Sankyo Company
  • Novo Nordisk A/S
  • Shire Plc
  • MORE
Asia Pacific was the largest region in the global hematology drugs market, accounting for 35% of the market in 2019. North America was the second largest region accounting for 27% of the global hematology drugs market. Africa was the smallest region in the global hematology drugs market.

The increase in the number of drug approvals for hemophilia by the regulatory bodies such as FDA in the US is an emerging trend in the market. For instance, in June 2017, Novo Nordisk received FDA approval for its Rebinyn (Coagulation Factor IX (Recombinant), GlycoPEGylated) drug that is used in the treatment of hemophilia B. Over the last 17 years, there were no new drug approvals for the treatment of hemophilia. However, there has been an uptake in the approval of new drugs for the treatment of hemophilia. From 2014 to 2017, seven new drugs have been approved by the FDA for treating hemophilia A and B. Increasing number of new FDA approved drugs aids in management of hemophilics and improves their Quality of Life (QoL).

The hematology drugs market consists of sales of hematology drugs and related services by entities (organizations, sole traders and partnerships) that produce hematology drugs to treat diseases such as genetic disorders, anemia, other related diseases. This industry includes establishments that produce blood products such as red blood cells, white blood cells, platelets, and fresh frozen plasma. It also consists of establishments which produce of anemia and other blood disorder drugs to treat anemia, hemophilia and blood clots.

The global hematology drugs market is expected to decline from $82.6 billion in 2019 to $76.5 billion in 2020 at a compound annual growth rate (CAGR) of -7.5%. The decline is mainly due to restrictions due to the coronavirus disease 2019 (COVID-19) pandemic and the measures to contain it. Some medical centers have canceled treatments, somehow put on hold, some have altered the policies and procedures to provide services. Also, many companies in the hematology drug market halted their business operations. All these factors have impacted the market growth. The market is then expected to recover and grow at a CAGR of 11% from 2021 and reach $124.6 billion in 2023. Optimistically, if the ongoing research on hematology drugs show any promising results for treating COVID-19 infection, the market is expected to grow significantly.
Note: Product cover images may vary from those shown
5 of 5
  • Novo Nordisk A/S
  • Shire Plc
  • Bayer AG
  • Daiichi Sankyo Company
  • Biogen Inc
Note: Product cover images may vary from those shown
6 of 5

Loading
LOADING...

Adroll
adroll